Medical Devices Procurement

Medical devices span an enormous range from simple wound dressings and surgical gloves to complex implantable cardiac devices, robotic surgical systems, and AI-powered diagnostic software. Their procurement by public health bodies is governed by two parallel regulatory systems: the product safety and market access regime (EU MDR/IVDR or UK MDR) and the public procurement regime (EU Directive 2014/24/EU or UK Procurement Act 2023). Both must be satisfied before a device can be supplied under a public contract.

What is Medical Devices Procurement?

Medical devices are classified by risk level, which determines the conformity assessment requirements a manufacturer must complete before placing products on the market.

EU classification and CE marking. Under EU Medical Devices Regulation 2017/745 (MDR) and In Vitro Diagnostic Regulation 2017/746 (IVDR), devices are classified as Class I, IIa, IIb, or III (Class A to D for IVDs). Higher-risk classes require involvement of a Notified Body in the conformity assessment. All devices sold in EU member states must bear a CE mark demonstrating conformity. The EU MDR fully replaced the previous Medical Devices Directive (MDD) regime, though transitional provisions apply for devices certified under the older directives where Notified Body capacity has constrained re-certification timelines.

UK UKCA marking. In the UK, devices must carry UKCA marking for the Great Britain market (England, Scotland, Wales). Northern Ireland continues to accept CE marking under the Windsor Framework. The MHRA is the UK regulator for medical devices. Manufacturers selling in both EU and UK markets must manage separate conformity assessment pathways, which increases compliance costs for smaller suppliers.

Procurement process. Above the threshold of 221,000 euros (EU) or equivalent UK threshold, medical devices contracts must be competitively tendered. Contracting authorities typically run open or restricted procedures. Award criteria for capital equipment (such as MRI scanners or surgical robots) commonly include technical capability, clinical functionality, whole-life cost, after-sales service, and compatibility with existing hospital infrastructure. Consumables and commoditised devices are more often awarded on a lowest-price-per-specification basis.

Framework agreements are widely used for medical devices across European health systems. In the UK, NHS Supply Chain manages frameworks covering most clinical device categories. In EU member states, central purchasing bodies such as UGAP in France and CONSIP in Italy manage national frameworks that individual hospitals call off from, reducing the procurement burden on individual contracting authorities.

Why it matters for bidders

Medical devices suppliers must manage the regulatory and commercial dimensions simultaneously. A device without a valid CE mark or UKCA mark cannot legally be supplied under a public contract and will be disqualified at the qualification stage. Maintaining up-to-date certificates and ensuring clinical evidence meets the strengthened requirements of EU MDR 2017/745, particularly for higher-risk Class IIb and III devices, is a significant ongoing compliance burden that smaller suppliers may find challenging.

For healthcare supply chain framework contracts, suppliers should expect to submit detailed product dossiers, interoperability statements, and post-market surveillance summaries as part of tender qualification documents. Capital equipment tenders often include clinical evaluation requirements and may involve structured demonstrations or site visits before award.

Example

A manufacturer of orthopaedic implants wishes to secure a place on a European hospital consortium framework for hip and knee replacement systems. Its Class III devices carry CE marking under EU MDR 2017/745 with Notified Body certification. It submits a technical dossier covering clinical evidence, post-market surveillance data, and implant registry participation. Award criteria include clinical outcomes data (30%), implant longevity evidence (25%), technical support and revision service (25%), and price (20%). Its strong registry outcomes data gives it a competitive advantage over lower-priced competitors with less published evidence.

Frequently Asked Questions

Does EU MDR apply to software used in medical devices?

Yes. Software that meets the definition of a medical device under EU MDR 2017/745 (software intended to be used for a medical purpose such as diagnosis, prognosis, monitoring, or treatment) must be classified and CE-marked accordingly. This includes diagnostic AI software and clinical decision support tools. Contracting authorities increasingly require MDR compliance evidence for health IT systems that interact with patient data for diagnostic or treatment purposes.

Can a hospital sole-source a medical device from a single supplier?

In exceptional circumstances, yes. Directive 2014/24/EU and the UK Procurement Act 2023 permit negotiated procedure without prior publication where only one supplier can technically deliver the requirement. This applies to proprietary systems with no equivalent alternative. The burden of justification is high and the decision is challengeable. Most sole-source medical device awards relate to compatible consumables or accessories for existing installed equipment.

What is the impact of the EU MDR transition on procurement timelines?

The transition from EU MDD to EU MDR has created supply disruptions for some device categories because manufacturers have not completed re-certification under the new regime. Contracting authorities in EU member states have experienced shortages of certain devices whose CE certificates lapsed during the transition. Procurement teams should verify the validity of MDR certificates at the time of contract award, not just at the time of tender submission.